Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Nafamostat mesilate

EU orphan designation number: EU/3/10/782   
Active ingredient: Nafamostat mesilate
Indication: Treatment of cystic fibrosis
Sponsor: Mucokinetica Ltd
53 Cavendish Road, London SW12 0BL, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/09/2010 Orphan designation EMA/OD/040/10 (2010)6649 of 20/09/2010